CRISPR, KSQ Therapeutics join forces to advance cell therapies in oncology

Image: CRISPR and KSQ Therapeutics sign license agreement to advance their respective cell therapy programs in oncology. Photo: courtesy of Darwin Laganzon from Pixabay.